Robert Hi Andtbacka
Overview
Explore the profile of Robert Hi Andtbacka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
2
Citations
58
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McNeal A, Belote R, Zeng H, Urquijo M, Barker K, Torres R, et al.
Elife
. 2021 Nov;
10.
PMID: 34812139
Benign melanocytic nevi frequently emerge when an acquired mutation triggers unchecked proliferation and subsequent arrest in melanocytes. Recent observations have challenged the role of oncogene-induced senescence in melanocytic nevus formation,...
2.
Harrington K, Andtbacka R, Collichio F, Downey G, Chen L, Szabo Z, et al.
Onco Targets Ther
. 2016 Nov;
9:7081-7093.
PMID: 27895500
Objectives: Talimogene laherparepvec is the first oncolytic immunotherapy to receive approval in Europe, the USA and Australia. In the randomized, open-label Phase III OPTiM trial (NCT00769704), talimogene laherparepvec significantly improved...